|
---|
Category:Meeting Agenda
MONTHYEARML24201A1792024-08-29029 August 2024 ACMUI Regulatory Basis on Financial Assurance Requirements Teleconference August 29 2024 Agenda - 1 ML24184B0942024-08-29029 August 2024 ACMUI Regulatory Basis on Financial Assurance Requirements Teleconference August 29 2024 Agenda ML24178A4442024-06-17017 June 2024 June 17 2024 Summary of Meeting Advisory Committee on the Medical Uses of Isotopes (ACMUI) ML24144A2142024-06-17017 June 2024 ACMUI Extravasations Teleconference June 17 2024 Agenda ML24149A1882024-06-0505 June 2024 ACMUI June 5 2024 Meeting Handout ML24130A0272024-06-0505 June 2024 ACMUI T & E Teleconference June 5 2024 Agenda ML24059A1962024-04-0808 April 2024 ACMUI Spring 2024 April 8-9 Agenda ML24117A2742024-04-0808 April 2024 April 8 2024 Summary of Meeting Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2024 ML24117A0482024-04-0808 April 2024 April 8 2024 Summary of Meeting Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2024 ML24088A2752024-04-0808 April 2024 ACMUI April 8 - 9, 2024 Meeting Handout ML24087A1512024-04-0808 April 2024 ACMUI Spring 2024 April 8-9 Agenda ML24059A4502024-04-0808 April 2024 ACMUI Spring 2024 April 8-9 Agenda ML23285A2892023-10-24024 October 2023 October 23-24, 2023 Meeting Agenda ML23125A3162023-05-15015 May 2023 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2023 Meeting Handout, May 15, 2023 ML23104A0612023-04-14014 April 2023 Advisory Committee on the Medical Uses of Isotopes (ACMUI) May 15-16, 2023 Meeting Agenda ML22304A0492022-10-31031 October 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Agenda December 5-6, 2022 ML22122A0612022-04-0505 April 2022 ACMUI Spring April 5, 2022 Meeting Summary ML22094A1022022-04-0505 April 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Revised Handout ML22060A2302022-04-0505 April 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) April 5, 2022 Meeting Agenda ML22089A1902022-03-30030 March 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Revised Agenda April 5, 2022 ML21341B4362021-12-15015 December 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) December 15, 2021 Teleconference Meeting Handout ML21270A1092021-09-27027 September 2021 Final ACMUI October 4 Meeting Agenda ML21159A2202021-07-15015 July 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) July 15, 2021 Teleconference Meeting Agenda ML21068A1912021-03-16016 March 2021 Revised Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 16, 2021 Meeting Agenda ML21035A2262021-03-16016 March 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 16, 2021 Meeting Agenda ML20311A5162020-10-29029 October 2020 Summary of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2020 Meeting, September 21-22, 2020 ML20212L8632020-07-30030 July 2020 Advisory Committee on the Medical Uses of Isotopes (ACMUI) September 21-22, 2020 Meeting Agenda ML20143A2382020-05-11011 May 2020 Summary of the Spring 2020 Meeting of the Advisory Committee on the Medical Uses of Isotopes (Acmui), March 30, 2020 ML20105A1982020-04-14014 April 2020 Advisory Committee on the Medical Uses of Isotopes (ACMUI) April 30, 2020 Teleconference Meeting Agenda ML20115E3952020-03-30030 March 2020 Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 30, 2020 Meeting Ebinder, Revised ML20056D9002020-02-25025 February 2020 Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 30-31, 2020 Meeting Agenda ML19274C0172019-10-17017 October 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) October 17, 2019 Teleconference Meeting Agenda ML19219B3152019-09-10010 September 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) September 10-11, 2019 Meeting Agenda ML19247E2822019-09-0404 September 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) September 10-11, 2019 Meeting Ebinder ML19190A3052019-07-24024 July 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) July 24, 2019 Teleconference Meeting Agenda ML19067A2392019-03-0808 March 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) April 3-4, 2019 Meeting Agenda ML19032A5132019-02-0101 February 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) February 26, 2019 Teleconference Meeting Agenda ML18256A4042018-09-13013 September 2018 Advisory Committee on the Medical Uses of Isotopes (ACMUI) September 20-21, 2018 Meeting Agenda, Final Agenda ML18225A2662018-08-13013 August 2018 09/20-21/2018 Meeting Agenda of Advisory Committee on the Medical Uses of Isotopes (ACMUI) ML18033B3492018-03-0707 March 2018 Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 7-8, 2018 Meeting Agenda ML18033B0172018-02-0101 February 2018 Advisory Committee on the Medical Uses of Isotopes (ACMUI) February 15, 2018 Teleconference Meeting Ebinder ML18029A9352018-01-29029 January 2018 Advisory Committee on the Medical Uses of Isotopes March 1, 2018 Teleconference Meeting Agenda ML18029A9362018-01-29029 January 2018 Advisory Committee on the Medical Uses of Isotopes February 15, 2018 Teleconference Meeting Agenda 2024-08-29
[Table view]Some use of "" in your query was not closed by a matching "". |
Text
MEETING AGENDA ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES September 10-11, 2019 Two White Flint North Building (T-2D30), Rockville, Maryland NOTE: Sessions of the meeting may be closed pursuant to 5 U.S.C. 552(b) to discuss organizational and personnel matters that relate solely to internal personnel rules and practices of the ACMUI; information the release of which would constitute a clearly unwarranted invasion of personal privacy; information the premature disclosure of which would be likely to significantly frustrate implementation of a proposed agency action; and disclosure of information which would risk circumvention of an agency regulation or statute.
Tuesday, September 10, 2019 CLOSED SESSION 7:30 - 8:30 1. Badging and Enrollment ACMUI OPEN SESSION
- 2. Opening Remarks C. Einberg, NRC Mr. Einberg will formally open the meeting and Ms. Kock will provide A. Kock, NRC opening remarks.
- 3. Old Business K. Jamerson, NRC Ms. Jamerson will review past ACMUI recommendations and provide NRC responses.
8:30 - 10:30 4. Open Forum ACMUI The ACMUI will identify medical topics of interest for further discussion.
- 5. Training and Experience Evaluation M. Ayoade, NRC Ms. Lopas and Ms. Ayoade will provide an update on the staffs S. Lopas, NRC evaluation of the training and experience requirements for radiopharmaceuticals requiring a written directive.
- 6. Medical Events Subcommittee Report R. Ennis, ACMUI Dr. Ennis will provide an analysis of FY18 medical events.
10:30 - 10:45 BREAK
- 7. Appropriateness of Medical Event Reporting Subcommittee R. Ennis, ACMUI Report Dr. Ennis will discuss the subcommittees recommendations on the 10:45 - 12:15 appropriateness of the required medical event reporting in accordance with 10 CFR 35.3045.
- 8. Evaluation of Infiltrations Subcommittee Report M. Martin, ACMUI Ms. Martin will discuss the subcommittees recommendations on the evaluation of the NRCs 1980 infiltration decision.
12:15 - 1:30 LUNCH 1
- 9. Special Presentation to Dr. Palestro K. Svinicki, NRC Chairman Svinicki will make a special presentation to Dr. Palestro.
- 10. Dr. Palestros Thoughts on Leaving the ACMUI C. Palestro, ACMUI 1:30 - 2:45 Dr. Palestro will share his thoughts on leaving the ACMUI, after serving eight years, two of which he served as ACMUI Chairman.
- 11. Xcision GammaPod Licensing Guidance Subcommittee H. Wolkov, ACMUI Report Dr. Wolkov will discuss the subcommittees recommendations on the NRCs draft Xcision GammaPod Licensing Guidance.
2:45 - 3:00 BREAK Tuesday, September 10, 2019 CLOSED SESSION
- 12. INFOSEC Training R. Norman, NRC 3:00 - 5:00 13. Ethics Training C. Safford, NRC
- 14. Allegations Training S. Hawkins, NRC Wednesday, September 11, 2019 OPEN SESSION
- 15. Reducing Radioactive Materials M. Taalbi, NNSA Ms. Taalbi will provide an overview of the NNSAs initiative to reduce radioactive materials using alternative technologies.
- 16. ACMUIs Institutional Memory Subcommittee Report A. Schleipman, Dr. Schleipman will discuss the subcommittees recommendations ACMUI 8:30 - 10:30 for improving the ACMUIs institutional memory.
- 17. Open Forum ACMUI The ACMUI will discuss medical topics of interest previously identified.
- 18. ACMUI External Communications C. Palestro, ACMUI Dr. Palestro will discuss the 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
10:30 - 10:45 BREAK
- 19. NRC Regulatory Process and Other Tools I. Irvin, NRC NRC staff will provide an overview of NRCs regulatory process, to include the lifecycle of ACMUI recommendations and open items from initiation to disposition.
10:45 - 11:15
- 20. Status of Emerging Technologies Licensed under 10 CFR M. Sheetz, ACMUI 35.1000 Mr. Sheetz will provide a presentation on the status of emerging technologies licensed under 10 CFR 35.1000.
2
- 21. U.S. Pharmacopeia (USP) General Chapter <825> R. Green, ACMUI Mr. Green will provide a presentation on the new USP General Chapter <825> for Radiopharmaceuticals.
11:45 - 1:00 22. ACMUI Membership Composition and Balance L. Dimmick, NRC Ms. Dimmick will provide a discussion of the ACMUI membership and balance.
- 23. Administrative Closing K. Jamerson, NRC Ms. Jamerson will provide a meeting summary and propose dates for the spring 2020 meeting.
1:00 ADJOURN 3